Inhibitor scaffolds as new allele specific kinase substrates

Area of Science:

• Biochemistry
• Molecular Biology
• Chemical Biology

Background:

• The protein kinase superfamily is vast (>500 human kinases), making the elucidation of signaling networks challenging.
• Existing methods for kinase research face limitations in specificity and efficiency.
• Targeted labeling of kinase protein substrates is crucial for understanding cellular signaling.

Purpose of the Study:

• To develop a new class of orthogonal triphosphate substrate analogues for direct labeling of specific kinase protein targets.
• To assess the substrate specificity and catalytic efficiency of these novel analogues compared to ATP.
• To demonstrate the utility of these analogues for kinase labeling in complex biological samples.

Main Methods:

• Synthesis of orthogonal triphosphate substrate analogues, including 3-benzylpyrazolopyrimidine triphosphate (3-benzyl-PPTP), based on Src family kinase inhibitor PP1 structures.
• Enzymatic assays to determine the substrate preference and catalytic efficiency (kcat/KM) of 3-benzyl-PPTP for various kinases, including mutant p38, v-Src, and CDK2/cyclin E.
• Kinase protein substrate labeling experiments using [gamma-(32)P]-3-benzyl-PPTP in murine spleenocyte cell lysates to assess orthogonality and efficiency against wild-type kinases and cellular ATP levels.

Main Results:

• 3-Benzyl-PPTP was found to be a substrate for mutant p38 and was preferred by v-Src (T338G) over ATP and N(6)-(benzyl)-ATP.
• For CDK2 (F80G)/cyclin E, 3-benzyl-PPTP exhibited catalytic efficiency comparable to ATP, primarily due to a significantly lower K(M).
• Both 3-benzyl-PPTP and 3-phenyl-PPTP demonstrated over 4-fold greater orthogonality than N(6)-(benzyl)-ATP in labeling wild-type kinases from murine spleenocytes.
• [gamma-(32)P]-3-benzyl-PPTP effectively labeled direct protein substrates of CDK2 (F80G)/E in cell lysates, even with high cellular ATP concentrations.

Conclusions:

• A new class of highly orthogonal triphosphate substrate analogues has been developed for specific kinase labeling.
• These analogues exhibit broad substrate acceptance across divergent kinases, suggesting potential generalizability to the entire kinase superfamily.
• The developed analogues offer a powerful tool for dissecting kinase signaling networks and identifying direct kinase substrates in complex cellular systems.